MedEquities Realty Trust (NYSE: MRT) reported Q2 EPS of $0.10, versus $0.17 reported last year. Revenue for the quarter came in at $17.56 million versus the consensus estimate of $16.96 million.

• Reported results attributable to common stockholders for the second quarter of 2018 of net income of $0.10 per diluted share, Funds from Operations (\"FFO\") of $0.23 per diluted share, both of which include the impact of $0.06 per diluted share in higher general and administrative expenses as described below, and Adjusted FFO (\"AFFO\") of $0.30 per diluted share.
• During the second quarter, invested $30.4 million in two inpatient rehabilitation hospitals (\"IRF\") and funded $2.8 million on existing mortgage loan commitments.
• Updated 2018 per share guidance for net income attributable to common stockholders to $0.60 to $0.61, FFO to $1.13 to $1.15 and AFFO to $1.19 to $1.22.
• Declared a regular cash dividend of $0.21 per share for the second quarter of 2018.

John W. McRoberts, the Company\'s Chief Executive Officer and Chairman, noted, "The investment pace is in line with our full year expectations. With the recent transactions, we have now closed and funded $57 million in investments in 2018 with an additional $13 million that is expected to fund before year end and an active pipeline of new opportunities. Our focus has been on smaller portfolio and individual transactions across the acute and post-acute continuum of care that meet our yield, asset type and underwriting standards. We remain committed to a strategy that can best capitalize on these growth opportunities."

GUIDANCE:

MedEquities Realty Trust sees FY2018 EPS of $0.60-$0.61, versus the consensus of $0.69.

For earnings history and earnings-related data on MedEquities Realty Trust (MRT) click here.